Mutation Find Bolsters Prospects for Alzheimer’s Drugs

The discovery of a rare genetic mutation that prevents formation of brain plaques associated with Alzheimer’s disease may be proof that the idea behind a new class of drugs in development is valid, scientists said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.